You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

ID: SCT 5 Aug 2013
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
C. Bredeson, R.B. Rumble, N.P. Varela, J. Kuruvilla, C.T. Kouroukis, Stem Cell Transplant Steering Committee

Patient Population

Adult and paediatric patients who have received an allogeneic transplant and are experiencing graft-versus-host disease.

Research Question(s)

Is there a benefit associated with the use of extra-corporeal photopheresis (ECP) compared with other treatment options for patients who have received an allogeneic transplant and are experiencing graft-versus-host disease (GVHD) if response rate, survival, or improvement in symptoms are the outcomes of interest?

pdf download Summary (PDF) (169.29 KB)
pdf download Full Report (PDF) (496.98 KB)